Venous thromboembolism.
Blann
Andrew D
AD
Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH. a.blann@bham.ac.uk
Lip
Gregory Y H
GY
D000925:Anticoagulants / Q000627:therapeutic use; D000077425:Fondaparinux; D005544:Forecasting; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D011134:Polysaccharides / Q000627:therapeutic use; D011655:Pulmonary Embolism / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D012307:Risk Factors; D013923:Thromboembolism / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D015912:Thrombolytic Therapy / Q000379:methods; D020246:Venous Thrombosis / Q000209:etiology / Q000517:prevention & control / Q000628:therapy; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D011134:Polysaccharides; D014812:Vitamin K; D000077425:Fondaparinux